Unrevealing the Natural Course of the So-called "inactive HBsAg or HBV Carrier State"

Overview

Journal Hepatol Int

Publisher Springer

Specialty Gastroenterology

Date 2009 Aug 12

PMID 19669350

Citations 5

Authors

Stephanos J Hadziyannis

Affiliations

Soon will be listed here.

Citing Articles

Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase.

Huang D, Cai Q, Zhou G, Yu H, Zhu Z, Peng J World J Hepatol. 2024; 16(6):920-931.

PMID: 38948441 PMC: 11212651. DOI: 10.4254/wjh.v16.i6.920.

The incidence of hepatocellular carcinoma and clearance of hepatitis B surface for CHB patients in the indeterminate phase: a systematic review and meta-analysis.

Liu M, Zhao T, Zhang Y, Zhang A, Geng J, Xia X Front Cell Infect Microbiol. 2023; 13:1226755.

PMID: 37771696 PMC: 10523783. DOI: 10.3389/fcimb.2023.1226755.

Definition and classification of acute-on-chronic liver diseases.

Zhang Y, Meng Z World J Clin Cases. 2022; 10(15):4717-4725.

PMID: 35801045 PMC: 9198886. DOI: 10.12998/wjcc.v10.i15.4717.

Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV Infection.

Graf C, Mondorf A, Knop V, Peiffer K, Dietz J, Friess J J Clin Med. 2019; 8(12).

PMID: 31810183 PMC: 6947378. DOI: 10.3390/jcm8122101.

HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.

Alexopoulou A, Karayiannis P World J Gastroenterol. 2014; 20(24):7644-52.

PMID: 24976702 PMC: 4069293. DOI: 10.3748/wjg.v20.i24.7644.

References

Alter H, Blumberg B . Further studies on a "new" human isoprecipitin system (Australia antigen). Blood. 1966; 27(3):297-309. View

Liaw Y, Leung N, Guan R, Lau G, Merican I . Asian-Pacific consensus statement on the management of chronic hepatitis B: an update. J Gastroenterol Hepatol. 2003; 18(3):239-45. DOI: 10.1046/j.1440-1746.2003.03037.x. View

Manno M, Camma C, Schepis F, Bassi F, Gelmini R, Giannini F . Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. Gastroenterology. 2004; 127(3):756-63. DOI: 10.1053/j.gastro.2004.06.021. View

Villeneuve J, Desrochers M, Infante-Rivard C, Willems B, Raymond G, Bourcier M . A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology. 1994; 106(4):1000-5. DOI: 10.1016/0016-5085(94)90760-9. View

Lok A, McMahon B . Chronic hepatitis B. Hepatology. 2007; 45(2):507-39. DOI: 10.1002/hep.21513. View

Sakuma K, Takahara T, Okuda K, Tsuda F, Mayumi M . Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests: a prospective study. Gastroenterology. 1982; 83(1 Pt 1):114-7. View

Hadziyannis S, Gerber M, Vissoulis C, Popper H . Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. Arch Pathol. 1973; 96(5):327-30. View

Hadziyannis S, LIEBERMAN H, Karvountzis G, Shafritz D . Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus. Hepatology. 1983; 3(5):656-62. DOI: 10.1002/hep.1840030505. View

Hadziyannis S, Vassilopoulos D . Hepatitis B e antigen-negative chronic hepatitis B. Hepatology. 2001; 34(4 Pt 1):617-24. DOI: 10.1053/jhep.2001.27834. View

10.

Chien R, Yeh C, Sheen I, Chiou H, Chu C, Liaw Y . Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology. 2002; 35(6):1522-7. DOI: 10.1053/jhep.2002.33638. View

11.

Chu C, Hung S, Lin J, Tai D, Liaw Y . Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med. 2004; 116(12):829-34. DOI: 10.1016/j.amjmed.2003.12.040. View

12.

Shafritz D, Shouval D, Sherman H, Hadziyannis S, Kew M . Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med. 1981; 305(18):1067-73. DOI: 10.1056/NEJM198110293051807. View

13.

de Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E . The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med. 1993; 118(3):191-4. DOI: 10.7326/0003-4819-118-3-199302010-00006. View

14.

Beasley R . Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988; 61(10):1942-56. DOI: 10.1002/1097-0142(19880515)61:10<1942::aid-cncr2820611003>3.0.co;2-j. View

15.

Chu C, Liaw Y . Spontaneous relapse of hepatitis in inactive HBsAg carriers. Hepatol Int. 2009; 1(2):311-5. PMC: 2716824. DOI: 10.1007/s12072-007-9002-9. View

16.

Manesis E, Papatheodoridis G, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis S . Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol. 2003; 98(10):2261-7. DOI: 10.1111/j.1572-0241.2003.07715.x. View

17.

Hadziyannis S, MERIKAS G, Panetsos S, KOUREPI M . Hepatitis associated antigen carriers among blood donors in Greece. Am J Dis Child. 1972; 123(4):381-3. DOI: 10.1001/archpedi.1972.02110100113041. View

18.

Lok A, McMahon B . Chronic hepatitis B: update of recommendations. Hepatology. 2004; 39(3):857-61. DOI: 10.1002/hep.20110. View

19.

Prince A . Relation of Australia and SH antigens. Lancet. 1968; 2(7565):462-3. DOI: 10.1016/s0140-6736(68)90512-6. View

20.

MUSHAHWAR I, Overby L, Frosner G, Deinhardt F, Ling C . Prevalence of hepatitis B e antigen and its antibody as detected by radioimmunoassays. J Med Virol. 1978; 2(2):77-87. DOI: 10.1002/jmv.1890020202. View